Shopping Cart
Remove All
Your shopping cart is currently empty
EGFR-IN-146 is an EGFR inhibitor that suppresses the EGFR signaling pathway and improves insulin sensitivity by activating the AMPK pathway. It effectively reduces blood glucose levels and body weight, showing great potential in the study of diabetes and obesity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | EGFR-IN-146 is an EGFR inhibitor that suppresses the EGFR signaling pathway and improves insulin sensitivity by activating the AMPK pathway. It effectively reduces blood glucose levels and body weight, showing great potential in the study of diabetes and obesity. |
| In vitro | EGFR-IN-146 (Compound 53) (10 μM) effectively enhances glucose uptake in the C2C12 cell model, serving a role in lowering blood sugar levels. |
| Molecular Weight | 312.368 |
| Formula | C20H16N4 |
| Cas No. | 166039-38-9 |
| Smiles | N=1C=CC=C(C1)CNC=2N=C(N=C3C=CC=CC32)C=4C=CC=CC4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.